50881-0010 Jakafi - CanMED: NDC

Product NDC:

50881-0010

Brand Name:

Jakafi

Generic Name:

Ruxolitinib

Dosage Form Name:

Tablet

Administration Route:

Oral

Substances:

Name: Ruxolitinib

Strength: 10.0

Unit: mg/1

Packages:

Code: 50881-0010-01

Description: 28 TABLET in 1 BOTTLE, PLASTIC (50881-010-01)

Effective Date: Nov. 16, 2011

Discontinued:

Code: 50881-0010-60

Description: 60 TABLET in 1 BOTTLE, PLASTIC (50881-010-60)

Effective Date: Nov. 16, 2011

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Enzyme Inhibitor

Minor Class:

JAK 1 and JAK 2 (Janus Kinase Inhibitor)

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox